Verification register Bio, Health & Neuro
Current reading
Readiness band and full integer triple
AI-assisted assembly · derived results
Readiness band
Emerging
Primary summary from verified readiness
- Confidence
- 82% · stale
- Computed at
- 2026-09-22T23:27:14.984527+00:00
- Claimed
- 30
- Reported
- 28
- Verified
- 25
- Gap
- +5
Public ambition and stated capability
Observed practitioner reporting
Independently supported evidence
Claimed leads verified
Evidence strength Strong
Decision
What the current evidence supports
Human editorial judgment · 2026-09-22
Wait for stronger evidence
- Why
- Striking mechanistic signal (sub-48h cold-to-hot shift) and a Nature Biomedical Engineering follow-up, but the human dataset is n=4 feasibility-only; vendor and NCI both flag it as very early. Cross-domain interest in the mRNA/LNP platform is high but clinical readiness is low.
- Next
- Track UF's expanded Phase I (up to 24 adult/pediatric patients, then ~25 children Phase 2 via the pediatric consortium) for first human safety + survival readouts before treating as a maturing modality. Note NCT07306299 is a SEPARATE Zhejiang University universal-mRNA glioma trial, not UF's.
Constraints
Blockers
No named blocker is present in the current public projection.
Evidence summary
Derived counts
AI-assisted assembly
- Total
- 7
- Tier 1
- 6
- Tier 2
- 1
- Tier 3
- 0
- Supports
- 2
- Contradicts
- 2
- Context
- 3
- Latest observed
- 2025-12-01
Counts and dates only. Raw signals, private excerpts, trust records, and internal corpus material are not published here.
Publication record
Revisions
Revision 2
- 2026-07-19 Reading moved from emerging to emerging.
- 2026-09-22 Reading moved from emerging to emerging.